Company News for July 2, 2013 - Corporate Summary

Comment

Shutterstock photo

•    Zynga Inc (NASDAQ: ZNGA ) said Don Mattrick will replace Mark Pincus as the CEO of the company, who will continue to be chairman and chief product officer  

•  Insmed Incorporated's (NASDAQ: INSM ) lung infection experimental drug failed to outperform competitor Novartis AG's (NYSE: NVS ) version. Following this development, shares of the company dropped nearly 19%

•    Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX ) jumped more than 50% after the company announced it is considering putting itself up for sale

•   Nokia Corporation (NYSE: NOK ) has purchased a 50%  stake in Nokia Siemens Networks from Siemens AG (NYSE: SI ) for $2.2 billion



INSMED INC (INSM): Free Stock Analysis Report

NOKIA CP-ADR A (NOK): Free Stock Analysis Report

NOVARTIS AG-ADR (NVS): Free Stock Analysis Report

ONYX PHARMA INC (ONXX): Free Stock Analysis Report

SIEMENS AG-ADR (SI): Free Stock Analysis Report

ZYNGA INC (ZNGA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Business , Investing Ideas , Stocks
Referenced Stocks: INSM , NOK , NVS , ONXX , SI


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com